Navigation Links
Avicena to Advance Huntington's Disease Clinical Program into Phase III

Avicena Group, Inc. (OTC Bulletin Board: AVGO), a late stage biotechnology company that develops central nervous system therapeutics for neurodegenerative diseases, announced today the selection of the optimal dose of HD-02, its novel drug candidate for the treatment of Huntington's Disease.

This dose was determined in an open-label dose escalation study, led by Dr. Steven Hersch and Dr. Diana Rosas of Massachusetts General Hospital (MGH), and will be further evaluated in a Phase III clinical trial.

The dose escalation study evaluated HD-02 in a range of doses from 10 to 40 grams per day and successfully determined the optimal dose that provided the maximum efficacy, safety and tolerability. The full scope of the data will be disseminated upon the results being peer reviewed.

Based on these findings, Avicena and its collaborators Dr. Hersch and the Huntington Study Group have developed a double-blind, placebo-controlled Phase III clinical trial anticipated to commence in early 2008. The Phase III trial will be one of the single largest trials for Huntington's patients, with external funding to be announced.

Upon commencement of this clinical trial, Avicena will have advanced three different indications into phase III trials that include some of the largest trial to date in both Parkinson's and Huntington's.

"We are very encouraged by the results of our HD-02 trial and we believe that in conjunction with our collaborators at MGH, we have identified the optimal dose as we move forward to validate HD-02 as a potential treatment for Huntington's disease, for which there is no current approved drug by the FDA.

We are committed to developing therapeutics that we hope can slow the progression of neurodegenerative diseases," stated Belinda Tsao-Nivaggioli, CEO of Avicena.

"We are excited by the results of our studies with HD-02 to date. This Phase III study will evaluat
'"/>




Page: 1 2

Related medicine news :

1. Advances in Treatment of Cataracts
2. Advanced STD programs required
3. Hope For Patients With Advanced Breast Cancer
4. Advances In Stem Cells Research
5. Breast Cancer Advance
6. Canadian Lung Cancer Study Lauded As Major Advance in Cancer Fight
7. Speedier Access To Advances In Breast Cancer Sought For Patients
8. HIV Vaccine Field Trials In Advanced Stage
9. Advance Funeral For AIDS-infected South African
10. New Screening Techniques to Lead Advances In Pain Therapy
11. Twin Treatment Could Be Used Increase Survival Rates In Advanced Melanoma
Post Your Comments:
(Date:8/3/2015)... ... 03, 2015 , ... Representatives with Health Food Grocers today announced ... ‘Ask a Nutritionist’ feature on our website is a free service to our community ... and spokeswoman for Health Food Grocers. , Health Food Grocers’ website offers a variety ...
(Date:8/3/2015)... ... August 03, 2015 , ... Code , an industry ... cable , a Bluetooth Code Reader accessory that enables a wireless connection between the ... T500 helps enable a variety of barcode reading applications with iPads, Galaxy Tabs, and ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... ... the Atlanta Journal Constitution, the new Lifetime reality series, “Atlanta Plastic” is getting ... and who receives plastic surgery, with its predominantly African-American cast of doctors and ...
(Date:8/3/2015)... ... August 03, 2015 , ... They know every second counts. ... Vincent Medical Center offers some of the best care in the nation. For the ... achieved the fastest average blood clot removal time in the country. During the months ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... ruled in favor of the firm’s client Rebecca Hamsher, deciding that in accordance ... must reimburse benefits for Hamsher’s residential treatment for bulimia, depression and other mental ...
Breaking Medicine News(10 mins):Health News:Health Food Grocers Launches "Ask a Nutritionist" Service 2Health News:Health Food Grocers Launches "Ask a Nutritionist" Service 3Health News:Code Launches the T500, an Innovative Code Reader Accessory 2Health News:Code Launches the T500, an Innovative Code Reader Accessory 3Health News:Article on Lifetime’s New “Atlanta Plastic” Reality Series Underlines the Diversity of Today’s Plastic Surgery Patients, Says Plastic Surgeon Dr. J 2Health News:Article on Lifetime’s New “Atlanta Plastic” Reality Series Underlines the Diversity of Today’s Plastic Surgery Patients, Says Plastic Surgeon Dr. J 3Health News:Providence St. Vincent Stroke Care Recognized Among Best in the Country 2Health News:Providence St. Vincent Stroke Care Recognized Among Best in the Country 3Health News:Kantor & Kantor Announces North Cypress Medical Center Must Reimburse Benefits for Mental Health Treatment 2Health News:Kantor & Kantor Announces North Cypress Medical Center Must Reimburse Benefits for Mental Health Treatment 3
... and Podcast VOORHEES, N.J., Feb. 26 The ... is changing and has been marked by increasing ... the epidemic strain continues to be reported in ... States, and worldwide.To address the need for current ...
... Corporation (NYSE: CVS ) today announced ... Officer and Chief Administrative Officer, will be making ... Institutional Investors Conference on March 10, 2009. Mr. ... a.m. EDT. (Logo: http://www.newscom.com/cgi-bin/prnh/20090226/NE75914LOGO )An ...
... for Tired Baby BoomersMINNEAPOLIS, Feb. 26 ... findings indicating that Bioenergy Ribose(TM) lessens fatigue ... at the Scripps Integrative Conference(1). Bioenergy Ribose ... functional ingredient for foods and beverages as ...
... do not save more in treatment costs under ... are healthier, according to a recent study. , ... patients, payers and employers," said Dennis Scanlon, professor ... lead author of the study. "Assessing the financial ...
... appearing in the March 2009 issue of the ... lead to improvements in the efficacy of the current ... a new role for type I interferon, in which ... an immune response against the bacterium known to cause ...
... day be used as an ingredient in sunscreen, researchers say ... suggested that caffeine might offer some protection from skin cancer, ... what we believe to be the mechanism by which caffeine ... Paul Nghiem, an associate professor of dermatology at the University ...
Cached Medicine News:Health News:Interview with GI Experts: Discussions in Clostridium difficile 2Health News:CVS Caremark Corporation to Present at the Raymond James Institutional Investors Conference on March 10th 2Health News:Bioenergy Ribose Found to Improve Vitality, Aerobic Fitness and Mental Outlook 2Health News:Bioenergy Ribose Found to Improve Vitality, Aerobic Fitness and Mental Outlook 3Health News:Team-based diabetes care fetches more value for dollar 2Health News:New discovery gives tuberculosis vaccine a shot in the arm 2Health News:Caffeine May Offer Some Skin Cancer Protection 2Health News:Caffeine May Offer Some Skin Cancer Protection 3
(Date:8/3/2015)... , Aug. 3, 2015  BC Technical, the nation,s ... Ohio Valley Medical Systems, one of the largest MRI ... addition of Ohio Valley Medical Systems allows BC Technical ... Hitachi MRI.   "We couldn,t be more ... President and CEO of BC Technical. "The Ohio Valley ...
(Date:8/3/2015)... HOUSTON and MINNEAPOLIS ... BSX ) has become a significant shareholder ... marketing representative for Preventice Solutions for cardiology-related diagnostic ... marks an important strategic milestone for Preventice Solutions," ... Global Strategy Officer, co CEO, Preventice Solutions.  "We ...
(Date:8/3/2015)... Ill. , Aug. 3, 2015 Your ... problem, and you,re looking for the best possible outcome. ... the best outcome too, and now there,s a ... Following steps recommended by the American Orthopaedic Foot ... surgery can help you avoid complications and heal as ...
Breaking Medicine Technology:BC Technical Acquires Ohio Valley Medical Systems 2Boston Scientific Announces Equity Investment And Sales Cooperation Agreement With Preventice Solutions 2Patient Guide: How to Prepare for Surgery 2
... ROCKVILLE, Md., Oct. 15 Novavax, Inc. (Nasdaq: ... Chief Executive Officer, and members of senior management will provide ... results via a webcast and conference call on Friday, November ... access the live audio webcast of the conference call, or ...
... CareFusion (NYSE: CFN ), a leading, global ... disclosed recall of approximately 17,000 Alaris® PC units model 8015 ... FDA has classified this action as a Class I recall. ... is a reasonable probability that the use of or exposure ...
Cached Medicine Technology:CareFusion Recall of Alaris PC Units Model 8015 Classified as Class I Recall 2CareFusion Recall of Alaris PC Units Model 8015 Classified as Class I Recall 3
Open 14 mm blades with 6 mm lifting wings. Dull finish....
Solid 14 mm blades. Dull finish....
Angled upward 45 degrees for temporal approach. Open 14 mm blades....
Pediatric model. Blades: 10 mm. Solid blades with locking mechanism. Dull finish....
Medicine Products: